How does the Malaysian public healthcare system cover cancer medication costs?

Question

Accepted Answer

Malaysian Public Healthcare Covers Cancer Medication Costs

The Malaysian public healthcare system covers the cost of cancer medication, such as Tamoxifen, for patients. While the prescribed hormone blockers can amount to nearly RM200 per month, these expenses are borne by the public system, significantly reducing the financial burden on individuals undergoing treatment.
Tamoxifen Prescription Duration

Patients undergoing treatment for certain cancers are prescribed hormone blockers like Tamoxifen for extended periods, typically ranging from five to ten years. This long-term medication regimen is a standard part of many cancer treatment protocols, aiming to prevent recurrence or manage the disease over time.
Monthly Medication Expenses

The financial outlay for hormone blockers like Tamoxifen can be substantial, with monthly costs approaching RM200. This figure highlights the potential financial strain on patients if such medications were not subsidised or covered by a healthcare system.
Public Healthcare System Coverage

Fortunately for patients in Malaysia, the prescribed cancer medications are included within the coverage of the nation's public healthcare system. This provision ensures that patients can access necessary treatments without facing prohibitive out-of-pocket expenses, allowing them to focus on their recovery.

Reading history

Hide →

This history is cleared when the page is closed.

How does the Malaysian public healthcare system cover cancer medication costs?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends